Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002519779 | SCV000283671 | uncertain significance | not provided | 2022-03-10 | criteria provided, single submitter | clinical testing | This sequence change replaces valine, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 84 of the FH protein (p.Val84Ala). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt FH protein function. ClinVar contains an entry for this variant (Variation ID: 237114). This variant has not been reported in the literature in individuals affected with FH-related conditions. This variant is not present in population databases (gnomAD no frequency). |
Fulgent Genetics, |
RCV000765098 | SCV000896307 | uncertain significance | Fumarase deficiency; Hereditary leiomyomatosis and renal cell cancer | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV002519779 | SCV004234788 | uncertain significance | not provided | 2023-05-08 | criteria provided, single submitter | clinical testing |